Genedrive PLC Director/PDMR Shareholding (1217C)
February 05 2020 - 11:39AM
UK Regulatory
TIDMGDR
RNS Number : 1217C
Genedrive PLC
05 February 2020
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the
near patient molecular diagnostics company, announces that Lisa
Miele, a Person Closely Associated with Gino Miele R&D Director
and a PDMR, acquired 8,636 ordinary shares of 1.5p each ("Ordinary
Shares") in the Company at a price of 8.875p per today.
Following these purchases, Gino Miele's total beneficial
interest is 66,979 Ordinary Shares, 0.2% of the issued share
capital of the Company.
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Lisa Miele
------------------------------ ----------------------------------------
2. Reason for the notification
------------------------------------------------------------------------
a. Position/status PCA of Gino Miele R&D Director
------------------------------ ----------------------------------------
a. Initial notification Initial notification
/Amendment
------------------------------ ----------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------
a. Name genedrive plc
------------------------------ ----------------------------------------
b. LEI 213800ZYODIRZ87Y4K14
------------------------------ ----------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------
a. Description of Ordinary shares of 1.5 pence each
the
Financial instrument,
type
of instrument GB00B1VKB244
Identification
code
------------------------------ ----------------------------------------
b. Nature of the Purchase
transaction
------------------------------ ----------------------------------------
c. Price(s) and Price(s) Volume(s)
volume(s) 8.875p 8,636
-----------------
------------------------------ ----------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ ----------------------------------------
e. Date of the transaction 2020-02-05
------------------------------ ----------------------------------------
f. Place of the London Stock Exchange, AIM
transaction
------------------------------ ----------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Matthew Fowler:
CFO
Peel Hunt LLP (Nominated Adviser and
Joint Broker) +44 (0)20 7418 8900
James Steel / Oliver Jackson
Stanford Capital Partners Limited
(Joint Broker) +44 (0)20 3815 8880
Patrick Claridge / John Howes
Walbrook PR Ltd (Media Relations & +44 (0)20 7933 8780 or genedrive@walbrookpr.com
Investor Relations)
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEAXASEDDEEFA
(END) Dow Jones Newswires
February 05, 2020 12:39 ET (17:39 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024
